A citation-based method for searching scientific literature

Michael J Elman, Lloyd Paul Aiello, Roy W Beck, Neil M Bressler, Susan B Bressler, Allison R Edwards, Frederick L Ferris, Scott M Friedman, Adam R Glassman, Kellee M Miller, Ingrid U Scott, Cynthia R Stockdale, Jennifer K Sun. Ophthalmology 2010
Times Cited: 918







List of co-cited articles
737 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
Quan Dong Nguyen, David M Brown, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Andrea Gibson, Judy Sy, Amy Chen Rundle, J Jill Hopkins,[...]. Ophthalmology 2012
51

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Lloyd Paul Aiello, Andrew N Antoszyk, Bambi Arnold-Bush, Carl W Baker, Neil M Bressler, David J Browning,[...]. N Engl J Med 2015
868
38

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Neil M Bressler, Susan B Bressler, Alexander J Brucker, Frederick L Ferris, G Robert Hampton, Chirag Jhaveri,[...]. Ophthalmology 2016
454
35

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
Paul Mitchell, Francesco Bandello, Ursula Schmidt-Erfurth, Gabriele E Lang, Pascale Massin, Reinier O Schlingemann, Florian Sutter, Christian Simader, Gabriela Burian, Ortrud Gerstner,[...]. Ophthalmology 2011
873
34

Global prevalence and major risk factors of diabetic retinopathy.
Joanne W Y Yau, Sophie L Rogers, Ryo Kawasaki, Ecosse L Lamoureux, Jonathan W Kowalski, Toke Bek, Shih-Jen Chen, Jacqueline M Dekker, Astrid Fletcher, Jakob Grauslund,[...]. Diabetes Care 2012
29

Intravitreal aflibercept for diabetic macular edema.
Jean-François Korobelnik, Diana V Do, Ursula Schmidt-Erfurth, David S Boyer, Frank G Holz, Jeffrey S Heier, Edoardo Midena, Peter K Kaiser, Hiroko Terasaki, Dennis M Marcus,[...]. Ophthalmology 2014
456
24

Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
Jeffrey S Heier, Jean-François Korobelnik, David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Edoardo Midena, David S Boyer, Hiroko Terasaki, Peter K Kaiser, Dennis M Marcus,[...]. Ophthalmology 2016
185
22

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.
David M Brown, Quan Dong Nguyen, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Patricio G Schlottmann, Amy Chen Rundle, Jiameng Zhang, Roman G Rubio,[...]. Ophthalmology 2013
533
22

Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Frank G Holz, David S Boyer, Edoardo Midena, Jeffrey S Heier, Hiroko Terasaki, Peter K Kaiser, Dennis M Marcus,[...]. Ophthalmology 2015
293
18

Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
David S Boyer, Young Hee Yoon, Rubens Belfort, Francesco Bandello, Raj K Maturi, Albert J Augustin, Xiao-Yan Li, Harry Cui, Yehia Hashad, Scott M Whitcup. Ophthalmology 2014
602
18

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Jeffrey G Gross, Adam R Glassman, Lee M Jampol, Seidu Inusah, Lloyd Paul Aiello, Andrew N Antoszyk, Carl W Baker, Brian B Berger, Neil M Bressler, David Browning,[...]. JAMA 2015
387
17


Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study.
Pascale Massin, Francesco Bandello, Justus G Garweg, Lutz L Hansen, Simon P Harding, Michael Larsen, Paul Mitchell, Dianne Sharp, U E K Wolf-Schnurrbusch, Margarita Gekkieva,[...]. Diabetes Care 2010
476
15

Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA).
Ursula Schmidt-Erfurth, Jose Garcia-Arumi, Francesco Bandello, Karina Berg, Usha Chakravarthy, Bianca S Gerendas, Jost Jonas, Michael Larsen, Ramin Tadayoni, Anat Loewenstein. Ophthalmologica 2017
236
14

Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.
Carl W Baker, Adam R Glassman, Wesley T Beaulieu, Andrew N Antoszyk, David J Browning, Kakarla V Chalam, Sandeep Grover, Lee M Jampol, Chirag D Jhaveri, Michele Melia,[...]. JAMA 2019
95
13


Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Michael J Elman, Neil M Bressler, Haijing Qin, Roy W Beck, Frederick L Ferris, Scott M Friedman, Adam R Glassman, Ingrid U Scott, Cynthia R Stockdale, Jennifer K Sun. Ophthalmology 2011
389
12

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.
Michel Michaelides, Andrew Kaines, Robin D Hamilton, Samantha Fraser-Bell, Ranjan Rajendram, Fahd Quhill, Christopher J Boos, Wen Xing, Catherine Egan, Tunde Peto,[...]. Ophthalmology 2010
326
12

Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.
Raj K Maturi, Adam R Glassman, Danni Liu, Roy W Beck, Abdhish R Bhavsar, Neil M Bressler, Lee M Jampol, Michele Melia, Omar S Punjabi, Hani Salehi-Had,[...]. JAMA Ophthalmol 2018
100
11


Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study.
Quan Dong Nguyen, Syed Mahmood Shah, Afsheen A Khwaja, Roomasa Channa, Elham Hatef, Diana V Do, David Boyer, Jeffery S Heier, Prema Abraham, Allen B Thach,[...]. Ophthalmology 2010
363
11

Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.
Ryan Lee, Tien Y Wong, Charumathi Sabanayagam. Eye Vis (Lond) 2015
557
11

Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Jeffrey G Gross, Adam R Glassman, Danni Liu, Jennifer K Sun, Andrew N Antoszyk, Carl W Baker, Neil M Bressler, Michael J Elman, Frederick L Ferris, Thomas W Gardner,[...]. JAMA Ophthalmol 2018
149
11

Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings.
Tien Y Wong, Jennifer Sun, Ryo Kawasaki, Paisan Ruamviboonsuk, Neeru Gupta, Van Charles Lansingh, Mauricio Maia, Wanjiku Mathenge, Sunil Moreker, Mahi M K Muqit,[...]. Ophthalmology 2018
195
10

Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema.
Jennifer K Sun, Michael M Lin, Jan Lammer, Sonja Prager, Rutuparna Sarangi, Paolo S Silva, Lloyd Paul Aiello. JAMA Ophthalmol 2014
227
10

Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.
Neil M Bressler, Wesley T Beaulieu, Adam R Glassman, Kevin J Blinder, Susan B Bressler, Lee M Jampol, Michele Melia, John A Wells. JAMA Ophthalmol 2018
111
9

Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study.
Christian Prünte, Franck Fajnkuchen, Sajjad Mahmood, Federico Ricci, Katja Hatz, Jan Studnička, Vladimir Bezlyak, Soumil Parikh, William John Stubbings, Andreas Wenzel,[...]. Br J Ophthalmol 2016
97
9

Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema.
Peter A Campochiaro, David M Brown, Andrew Pearson, Sanford Chen, David Boyer, Jose Ruiz-Moreno, Bruce Garretson, Amod Gupta, Seenu M Hariprasad, Clare Bailey,[...]. Ophthalmology 2012
300
9

Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets.
Arup Das, Paul G McGuire, Sampathkumar Rangasamy. Ophthalmology 2015
250
9

Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema.
Peter A Campochiaro, David M Brown, Andrew Pearson, Thomas Ciulla, David Boyer, Frank G Holz, Michael Tolentino, Amod Gupta, Lilianne Duarte, Steven Madreperla,[...]. Ophthalmology 2011
243
9

The REVEAL Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular Edema.
Tatsuro Ishibashi, Xiaoxin Li, Adrian Koh, Timothy Y Y Lai, Fenq-Lih Lee, Won-Ki Lee, Zhizhong Ma, Masahito Ohji, Nikolle Tan, Sung Bok Cha,[...]. Ophthalmology 2015
96
9

Diabetic Retinopathy: Pathophysiology and Treatments.
Wei Wang, Amy C Y Lo. Int J Mol Sci 2018
237
9

Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study).
Adam R Glassman, John A Wells, Kristin Josic, Maureen G Maguire, Andrew N Antoszyk, Carl Baker, Wesley T Beaulieu, Michael J Elman, Lee M Jampol, Jennifer K Sun. Ophthalmology 2020
23
39

Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year Outcomes.
John F Payne, Charles C Wykoff, W Lloyd Clark, Beau B Bruce, David S Boyer, David M Brown. Am J Ophthalmol 2019
28
28

Prevalence of and risk factors for diabetic macular edema in the United States.
Rohit Varma, Neil M Bressler, Quan V Doan, Michelle Gleeson, Mark Danese, Julie K Bower, Elizabeth Selvin, Chantal Dolan, Jennifer Fine, Shoshana Colman,[...]. JAMA Ophthalmol 2014
172
8

Real-world Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema in the United States.
Thomas A Ciulla, Peter Bracha, John Pollack, David F Williams. Ophthalmol Retina 2018
58
13

Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.
David J Browning, Adam R Glassman, Lloyd Paul Aiello, Roy W Beck, David M Brown, Donald S Fong, Neil M Bressler, Ronald P Danis, James L Kinyoun, Quan Dong Nguyen,[...]. Ophthalmology 2007
389
8

Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results.
Michael J Elman, Allison Ayala, Neil M Bressler, David Browning, Christina J Flaxel, Adam R Glassman, Lee M Jampol, Thomas W Stone. Ophthalmology 2015
218
8

Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice.
Nancy M Holekamp, Joanna Campbell, Arghavan Almony, Herbert Ingraham, Steven Marks, Hitesh Chandwani, Ashley L Cole, Szilárd Kiss. Am J Ophthalmol 2018
44
18

Early and Long-Term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I Data.
Victor H Gonzalez, Joanna Campbell, Nancy M Holekamp, Szilárd Kiss, Anat Loewenstein, Albert J Augustin, Julia Ma, Allen C Ho, Vaishali Patel, Scott M Whitcup,[...]. Am J Ophthalmol 2016
166
8

Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment.
Susan B Bressler, Allison R Ayala, Neil M Bressler, Michele Melia, Haijing Qin, Frederick L Ferris, Christina J Flaxel, Scott M Friedman, Adam R Glassman, Lee M Jampol,[...]. JAMA Ophthalmol 2016
95
8

Effects of medical therapies on retinopathy progression in type 2 diabetes.
Emily Y Chew, Walter T Ambrosius, Matthew D Davis, Ronald P Danis, Sapna Gangaputra, Craig M Greven, Larry Hubbard, Barbara A Esser, James F Lovato, Letitia H Perdue,[...]. N Engl J Med 2010
759
8

Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema.
Roy W Beck, Allison R Edwards, Lloyd P Aiello, Neil M Bressler, Frederick Ferris, Adam R Glassman, Elizabeth Hartnett, Michael S Ip, Judy E Kim, Craig Kollman. Arch Ophthalmol 2009
277
8


Ranibizumab for neovascular age-related macular degeneration.
Philip J Rosenfeld, David M Brown, Jeffrey S Heier, David S Boyer, Peter K Kaiser, Carol Y Chung, Robert Y Kim. N Engl J Med 2006
8


Outcomes with As-Needed Ranibizumab after Initial Monthly Therapy: Long-Term Outcomes of the Phase III RIDE and RISE Trials.
David S Boyer, Quan Dong Nguyen, David M Brown, Karen Basu, Jason S Ehrlich. Ophthalmology 2015
92
7

A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.
Ranjan Rajendram, Samantha Fraser-Bell, Andrew Kaines, Michel Michaelides, Robin D Hamilton, Simona Degli Esposti, Tunde Peto, Catherine Egan, Catey Bunce, Richard David Leslie,[...]. Arch Ophthalmol 2012
252
7

The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.
Diana V Do, Ursula Schmidt-Erfurth, Victor H Gonzalez, Carmelina M Gordon, Michael Tolentino, Alyson J Berliner, Robert Vitti, Rene Rückert, Rupert Sandbrink, David Stein,[...]. Ophthalmology 2011
173
7

Role of Inflammation in Diabetic Retinopathy.
Anne Rübsam, Sonia Parikh, Patrice E Fort. Int J Mol Sci 2018
231
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.